Aridana Sandika, I Made, et al. “Does Germline BRCA1 2 Status Modify the Effect of Neoadjuvant Pembrolizumab on Pathological Complete Response in Early-Stage Triple-Negative Breast Cancer? A Systematic Review and Meta-Analysis of Treatment-Biomarker Interactions”. Bioscientia Medicina : Journal of Biomedicine and Translational Research, vol. 10, no. 10, Aug. 2026, pp. 2896-08, https://doi.org/10.37275/bsm.v10i10.1658.